Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Adeno-Associated Viruses (AAV) and Host Immunity – A Race Between the Hare and the Hedgehog
Kleopatra Rapti, Dirk Grimm
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

CRISPR Modeling and Correction of Cardiovascular Disease
Ning Liu, Eric N. Olson
Circulation Research (2022) Vol. 130, Iss. 12, pp. 1827-1850
Open Access | Times Cited: 63
Fantastic AAV Gene Therapy Vectors and How to Find Them—Random Diversification, Rational Design and Machine Learning
Jonas Becker, Julia Fakhiri, Dirk Grimm
Pathogens (2022) Vol. 11, Iss. 7, pp. 756-756
Open Access | Times Cited: 53
Semirational bioengineering of AAV vectors with increased potency and specificity for systemic gene therapy of muscle disorders
Jihad El Andari, Edith Renaud-Gabardos, Warut Tulalamba, et al.
Science Advances (2022) Vol. 8, Iss. 38
Open Access | Times Cited: 46
Patchouli alcohol attenuates the cognitive deficits in a transgenic mouse model of Alzheimer’s disease via modulating neuropathology and gut microbiota through suppressing C/EBPβ/AEP pathway
Qingqing Xu, Ziren Su, Wen Yang, et al.
Journal of Neuroinflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 40
Primate-conserved carbonic anhydrase IV and murine-restricted LY6C1 enable blood-brain barrier crossing by engineered viral vectors
Timothy F. Shay, Erin E. Sullivan, Xiaozhe Ding, et al.
Science Advances (2023) Vol. 9, Iss. 16
Open Access | Times Cited: 30
Regulation of endogenous cardiomyocyte proliferation: The known unknowns
Ilaria Secco, Mauro Giacca
Journal of Molecular and Cellular Cardiology (2023) Vol. 179, pp. 80-89
Open Access | Times Cited: 23
Adeno-associated virus vector delivery to the brain: Technology advancements and clinical applications
Dezhuang Ye, Chinwendu Chukwu, Yaoheng Yang, et al.
Advanced Drug Delivery Reviews (2024) Vol. 211, pp. 115363-115363
Open Access | Times Cited: 9
AAV capsid prioritization in normal and steatotic human livers maintained by machine perfusion
Jae-Jun Kim, Simone N. T. Kurial, Pervinder K. Choksi, et al.
Nature Biotechnology (2025)
Open Access | Times Cited: 1
Structural and functional characterization of capsid binding by anti-AAV9 monoclonal antibodies from infants after SMA gene therapy
Grant J. Logan, Mario Mietzsch, Neeta Khandekar, et al.
Molecular Therapy (2023) Vol. 31, Iss. 7, pp. 1979-1993
Open Access | Times Cited: 20
Genome Editing VEGFA Prevents Corneal Neovascularization In Vivo
Zhenhai Zeng, Siheng Li, Xiuhong Ye, et al.
Advanced Science (2024) Vol. 11, Iss. 25
Open Access | Times Cited: 7
Advances and opportunities in process analytical technologies for viral vector manufacturing
Sobhana A. Sripada, Mahshid Hosseini, Srivatsan Ramesh, et al.
Biotechnology Advances (2024) Vol. 74, pp. 108391-108391
Closed Access | Times Cited: 5
Progress in Bioengineering of Myotropic Adeno-Associated Viral Gene Therapy Vectors
Jixin Liu, Teng Wei Koay, Olena Maiakovska, et al.
Human Gene Therapy (2023) Vol. 34, Iss. 9-10, pp. 350-364
Closed Access | Times Cited: 12
Deciphering conundrums of adeno-associated virus liver-directed gene therapy: focus on hemophilia
Glenn F. Pierce, Sylvia Fong, Brian Long, et al.
Journal of Thrombosis and Haemostasis (2023) Vol. 22, Iss. 5, pp. 1263-1289
Open Access | Times Cited: 11
Genetically engineered mesenchymal stem cells with dopamine synthesis for Parkinson’s disease in animal models
Jun Li, Nan Li, Jingkuan Wei, et al.
npj Parkinson s Disease (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 17
Biology, Pathobiology and Gene Therapy of CNG Channel-Related Retinopathies
Maximilian Gerhardt, Siegfried Priglinger, Martin Biel, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 269-269
Open Access | Times Cited: 10
Human cell surface-AAV interactomes identify LRP6 as blood-brain barrier transcytosis receptor and immune cytokine IL3 as AAV9 binder
Timothy F. Shay, Seongmin Jang, Tyler J. Brittain, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
Directed evolution of adeno-associated virus 5 capsid enables specific liver tropism
Yuqiu Wang, Chen Yang, Hanyang Hu, et al.
Molecular Therapy — Nucleic Acids (2022) Vol. 28, pp. 293-306
Open Access | Times Cited: 16
Muscle‐specific, liver‐detargeted adeno‐associated virus gene therapy rescues Pompe phenotype in adult and neonate Gaa−/− mice
Pauline Sellier, Pierre Vidal, Benjamin Bertin, et al.
Journal of Inherited Metabolic Disease (2023) Vol. 47, Iss. 1, pp. 119-134
Open Access | Times Cited: 8
Sustained release of therapeutic gene by injectable hydrogel for hepatocellular carcinoma
Shuangta Xu, J. Cai, Hongwei Cheng, et al.
International Journal of Pharmaceutics X (2023) Vol. 6, pp. 100195-100195
Open Access | Times Cited: 8
Novel assay format for total anti-adeno-associated virus antibody detection with low capsid consumption and built-in specificity control
Uwe Wessels, Florian Neff, Julia Fakhiri, et al.
Bioanalysis (2024) Vol. 16, Iss. 10, pp. 431-442
Open Access | Times Cited: 2
Combined 100 keV cryo-electron microscopy and image analysis methods to characterize the wider adeno-associated viral products
Haruka Nishiumi, Kiichi Hirohata, Mitsuko Fukuhara, et al.
Journal of Pharmaceutical Sciences (2024)
Closed Access | Times Cited: 2
Thrombotic Microangiopathy as an Emerging Complication of Viral Vector–Based Gene Therapy
Nora Schwotzer, Carine El Sissy, Isabelle Desguerre, et al.
Kidney International Reports (2024) Vol. 9, Iss. 7, pp. 1995-2005
Open Access | Times Cited: 2
Advances and Challenges in Gene Therapy for Alzheimer’s Disease
Fabiana Morroni, Antonella Caccamo
Journal of Alzheimer s Disease (2024) Vol. 101, Iss. s1, pp. S417-S431
Closed Access | Times Cited: 2
Emerging Perspectives on Gene Therapy Delivery for Neurodegenerative and Neuromuscular Disorders
Cintia Gomez Limia, Megan Baird, M. Schwartz, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 12, pp. 1979-1979
Open Access | Times Cited: 11
Adeno-associated virus vector system controlling capsid expression improves viral quantity and quality
Kenji Ohba, Yoshihide Sehara, Tatsuji Enoki, et al.
iScience (2023) Vol. 26, Iss. 4, pp. 106487-106487
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top